Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy
Wenzhe Zhao,
No information about this author
Kaixuan Li,
No information about this author
Liangbo Li
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(14), P. 7715 - 7715
Published: July 14, 2024
Exosomes
are
small
vesicles
containing
proteins,
nucleic
acids,
and
biological
lipids,
which
responsible
for
intercellular
communication.
Studies
have
shown
that
exosomes
can
be
utilized
as
effective
drug
delivery
vehicles
to
accurately
deliver
therapeutic
substances
target
tissues,
enhancing
effects
reducing
side
effects.
Mesenchymal
stem
cells
(MSCs)
a
class
of
widely
used
tissue
engineering,
regenerative
medicine,
immunotherapy.
derived
from
MSCs
special
immunomodulatory
functions,
low
immunogenicity,
the
ability
penetrate
tumor
high
yield,
expected
engineered
into
efficient
systems.
Despite
promising
promise
MSC-derived
exosomes,
exploring
their
optimal
preparation
methods,
drug-loading
modalities,
potential
remains
challenging.
Therefore,
this
article
reviews
related
characteristics,
application,
risks
systems
in
order
find
breakthroughs.
Language: Английский
Methods, Mechanisms, and Application Prospects for Enhancing Extracellular Vesicle Uptake
Ying-peng Xu,
No information about this author
Tao Jiang,
No information about this author
Xiaofan Yang
No information about this author
et al.
Current Medical Science,
Journal Year:
2024,
Volume and Issue:
44(2), P. 247 - 260
Published: April 1, 2024
Language: Английский
The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer
Nikola Odehnalová,
No information about this author
Viera Šandriková,
No information about this author
Róbert Hromádka
No information about this author
et al.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: March 13, 2025
Exosomes,
nanosized
extracellular
vesicles
released
by
various
cell
types,
are
intensively
studied
for
the
diagnosis
and
treatment
of
cancer
neurodegenerative
diseases,
they
also
display
high
usability
in
regenerative
medicine.
Emphasizing
their
diagnostic
potential,
exosomes
serve
as
carriers
disease-specific
biomarkers,
enabling
non-invasive
early
detection
personalized
The
cargo
loading
with
therapeutic
agents
presents
an
innovative
strategy
targeted
drug
delivery,
minimizing
off-target
effects
optimizing
interventions.
In
medicine,
play
a
crucial
role
intercellular
communication,
facilitating
tissue
regeneration
through
transmission
bioactive
molecules.
While
acknowledging
existing
challenges
standardization
scalability,
ongoing
research
efforts
aim
to
refine
methodologies
address
regulatory
considerations.
summary,
this
review
underscores
transformative
potential
reshaping
landscape
medical
interventions,
particular
emphasis
on
cancer,
Language: Английский
Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3424 - 3424
Published: April 5, 2025
The
use
of
adenosine
triphosphate
(ATP)
has
shown
promising
effects
in
alleviating
ischemic
damage
across
various
tissues.
However,
the
penetration
ATP
into
kidney
tubular
cells
presents
a
challenge
due
to
their
unique
anatomical
and
physiological
properties.
In
this
study,
we
introduce
novel
bioinspired
drug
delivery
system
utilizing
extracellular
vesicles
(EVs)
derived
from
mesenchymal
stromal
(MSCs)
engineered
carry
ATP.
ATP-loaded
liposomes
(ATP-LPs)
EVs
(ATP-EVs)
were
prepared
using
microfluidic
technology,
followed
by
characterization
morphology
(DLS,
NTA,
SEM,
TEM),
content,
release
rate
at
37
°C
(pH
7.4).
Additionally,
efficacy
ATP-LPs
ATP-EVs
was
evaluated
vitro
on
renal
(HK2
cells)
under
chemically
induced
ischemia.
results
indicated
successful
enrichment
EVs,
with
showing
no
significant
changes
or
size
compared
naïve
EVs.
Notably,
demonstrated
superior
retention
ATP-LPs,
protecting
degradation
environment.
an
ATP-depleted
HK2
cell
model,
only
effectively
restored
levels,
preserving
viability
reducing
apoptotic
gene
expression
(BCL2-BAX).
This
study
is
first
successfully
demonstrate
direct
as
carriers.
Language: Английский
Exosomes derived from human amniotic mesenchymal stem cells promotes angiogenesis in hUVECs by delivering novel miRNA N-194
Molecular Medicine,
Journal Year:
2025,
Volume and Issue:
31(1)
Published: May 6, 2025
Abstract
Background
To
investigate
the
effect
and
mechanism
of
exosomes
derived
from
human
amniotic
mesenchymal
stem
cells
(hAMSC-Exos)
promoting
angiogenesis.
Methods
HAMSC-Exos
were
isolated
using
ultracentrifugation
characterized
by
transmission
electron
microscopy,
NTA,
Western
blot.
The
uptake
hAMSC-Exos
hUVECs
was
analyzed
PKH-26
labeling,
on
angiogenesis
in
umbilical
vein
endothelial
cell
viability
assay,
Transwell
migration
Matrigel
tube
formation
plug
assays
nude
mice.
Bioinformatics
methods
used
to
analyze
miRNA
high-throughput
sequencing
data
hAMSC-Exos,
RT-qPCR
validate
novel
miRNAs.
with
high
low
N-194
expression
obtained
transfection,
respectively.
Target
genes
predicted
TargetScan,
mRNA
protein
levels
potential
target
blot
after
mimics
transfection.
Interaction
between
miRNAs
detected
dual-luciferase
reporter
assay.
overexpressed
roles
influence
function
determined
analyzing
Results
extracted
showed
saucer-shaped
under
NTA
results
particle
size
115.6
±
38.6
nm.
positive
CD9,
CD63,
CD81
verified
treatment
significantly
increased
proliferation,
migration,
contained
N-194,
N-314,
N-19,
N-393,
N-481,
higher.
Exos
hAMSCs
which
transfected
FAM-N-194
able
deliver
hUVECs.
promoted
transfection
reduced
gene
ING5,
luciferase
activities
expressed
wild-type
vectors
for
ING5.
ING5
overexpression
angiogenic
capacity
suppressed
HSP27
PLCG2.
Conclusions
promotes
delivering
targets
Graphical
Language: Английский
Exploring the Therapeutic Potential of Extracellular Vesicles Derived from Human Immature Dental Pulp Cells on Papillary Thyroid Cancer
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8178 - 8178
Published: July 26, 2024
Mesenchymal
stem-cell-derived
extracellular
vesicles
(MSC-EVs)
have
been
increasingly
investigated
for
cancer
therapy
and
drug
delivery,
they
offer
an
advanced
cell-free
therapeutic
option.
However,
their
overall
effects
efficacy
depend
on
various
factors,
including
the
MSC
source
cargo
content.
In
this
study,
we
isolated
EVs
from
conditioned
medium
of
human
immature
dental
pulp
stem
cells
(hIDPSC-EVs)
two
papillary
thyroid
(PTC)
cell
lines
(BCPAP
TPC1).
We
observed
efficient
uptake
hIDPSC-EVs
by
both
PTC
lines,
with
a
notable
impact
gene
regulation,
particularly
in
Wnt
signaling
pathway
BCPAP
cells.
no
significant
proliferation
were
observed.
Conversely,
significantly
reduced
invasive
capacity
after
120
h
treatment.
These
vitro
findings
suggest
potential
management
emphasize
need
further
research
to
develop
novel
effective
treatment
strategies.
Furthermore,
successful
internalization
underscores
use
as
nanocarriers
anti-cancer
agents.
Language: Английский
Application of extracellular vesicles in diabetic osteoporosis
Xiaopeng Jia,
No information about this author
G Zhang,
No information about this author
Dongmei Yu
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 10, 2024
As
the
population
ages,
occurrence
of
osteoporosis
is
becoming
more
common.
Diabetes
mellitus
one
factors
in
development
osteoporosis.
Compared
with
general
population,
incidence
significantly
higher
diabetic
patients.
Diabetic
(DOP)
a
metabolic
bone
disease
characterized
by
abnormal
tissue
structure
due
to
hyperglycemia
and
insulin
resistance,
reduced
strength
increased
risk
fractures.
This
complex
mechanism
that
occurs
at
cellular
level
such
as
blood
vessels,
inflammation,
resistance.
Although
application
some
drugs
clinical
practice
can
reduce
DOP,
fractures
caused
DOP
still
very
high.
Extracellular
vesicles
(EVs)
are
new
communication
mode
between
cells,
which
transfer
miRNAs
proteins
from
mother
cells
target
through
membrane
fusion,
thereby
regulating
function
cells.
In
recent
years,
role
EVs
pathogenesis
has
been
widely
demonstrated.
this
article,
we
first
describe
changes
microenvironment
Second,
DOP.
Finally,
summarize
research
progress
challenges
Language: Английский